
Mendaera
Founded Year
2020Stage
Series B | AliveTotal Raised
$97MLast Raised
$73M | 1 yr agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-22 points in the past 30 days
About Mendaera
Mendaera specializes in healthcare technology, focusing on robotics and artificial intelligence (AI) for medical procedures. The company develops a platform that integrates real-time imaging, robotics, and AI to support medical interventions. Mendaera's technology is intended to make healthcare services efficient and accessible. It was founded in 2020 and is based in San Mateo, California.
Loading...
ESPs containing Mendaera
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The interventional imaging software market provides solutions for medical professionals to improve the accuracy and efficiency of interventional radiology procedures using technology. These solutions utilize machine learning algorithms to analyze medical images and assist in decision-making during procedures. This technology can help to reduce diagnostic errors, improve treatment planning, and enh…
Mendaera named as Challenger among 15 other companies, including Viz.ai, Aidoc, and Qure.ai.
Loading...
Research containing Mendaera
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Mendaera in 2 CB Insights research briefs, most recently on Oct 20, 2025.

Oct 20, 2025 report
Digital Health 50: The most promising digital health startups of 2025Expert Collections containing Mendaera
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Mendaera is included in 3 Expert Collections, including Artificial Intelligence (AI).
Artificial Intelligence (AI)
20,894 items
Digital Health
12,122 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Digital Health 50
50 items
Mendaera Patents
Mendaera has filed 4 patents.
The 3 most popular patent topics include:
- 3d imaging
- image processing
- medical imaging

Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
11/4/2022 | 12/10/2024 | Telehealth, Surgery, Videotelephony, Job scheduling, Telemedicine | Grant |
Application Date | 11/4/2022 |
|---|---|
Grant Date | 12/10/2024 |
Title | |
Related Topics | Telehealth, Surgery, Videotelephony, Job scheduling, Telemedicine |
Status | Grant |
Latest Mendaera News
Sep 15, 2025
September 15, 2025 Mendaera , a healthcare technology company developing next-generation robotics technology to simplify ultrasound-guided needle procedures, today announced the world’s first procedures performed with the Focalist handheld robotic system. Urologist Karen Stern, MD, (Mayo Clinic Arizona) successfully used Focalist to achieve precise kidney access during percutaneous nephrolithotomy (PCNL), the gold standard treatment for large kidney stones. Dr Stern presented the milestone procedures at the World Conference on Endourology and Uro-Technology (WCET), a prestigious global meeting for surgeons advancing minimally invasive kidney stone treatment. PCNL begins with the placement of a needle into the kidney under imaging guidance, creating a pathway for stone removal. This critical first step requires extreme precision to avoid surrounding organs and to enable optimal and effective stone clearance. Using Focalist, Dr Stern and her team achieved rapid, efficient, and precise first-pass needle placement into the ideal kidney location. Dr Stern says: “I was thrilled to be the first in the world to use the Focalist System. I found it intuitive to learn and easy to integrate into my workflow. “Focalist enhances needle control and simplifies precise placement under ultrasound, particularly for operators with less experience. It has the potential to build confidence in ultrasound-guided access and lower the barrier to proficiency across providers with varying levels of experience.” The Focalist System combines handheld robotics, real-time ultrasound, and advanced software to enable precise, repeatable instrument placement. These first-in-the-world procedures mark the beginning of the limited US launch of Focalist in urology, with expansion to additional specialties planned in 2026. Josh DeFonzo, co-founder and CEO of Mendaera, says: “These first procedures underscore Focalist’s ability to deliver highly precise, consistent needle placement – a foundational requirement across all of medicine. “We’re proud to partner with Dr Stern as she pioneers ultrasound-guided access in urology. We believe Focalist will empower more healthcare providers to perform procedures with confidence. This milestone brings us closer to our mission of broadening access to minimally invasive procedures and elevating standards across the healthcare system.” The recorded case presentation by Dr Stern will be available in the coming weeks on the WCET website . Share this:
Mendaera Frequently Asked Questions (FAQ)
When was Mendaera founded?
Mendaera was founded in 2020.
Where is Mendaera's headquarters?
Mendaera's headquarters is located at 700 South Claremont Street, San Mateo.
What is Mendaera's latest funding round?
Mendaera's latest funding round is Series B.
How much did Mendaera raise?
Mendaera raised a total of $97M.
Who are the investors of Mendaera?
Investors of Mendaera include Fred Moll, Lux Capital, PFM Health Sciences, Threshold Ventures, Operator Partners and 9 more.
Loading...
Loading...
